Adamas Pharmaceuticals
$8.22
8
+$0.06+0.74% Tuesday 21:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
374.8M
P/E Ratio
-3.76
Dividend Yield
-
Dividend
-
Earnings
8NovExpected
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ADMS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Pharmaceuticals: Other
Manufacturing
Pharmaceutical Preparation Manufacturing
Adamas Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders in the United States. The company offers GOCOVRI, an extended release capsule for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications. It is also developing ADS-5102 that is in Phase III clinical study to treat walking impairment in patients with multiple sclerosis and other indications; and ADS-4101, which has completed two Phase I studies for treating partial onset seizures in patients with epilepsy. In addition, the company offers Namzaric (memantine hydrochloride extended release and donepezil hydrochloride) capsules for the treatment of moderate to severe dementia of an Alzheimer's type. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc. in July 2007. Adamas Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Emeryville, California.
Show more...
CEO
Neil McFarlane
Employees
138
Country
US
ISIN
US00548A1060
Listings
0 Comments
Share your thoughts
FAQ
What is Adamas Pharmaceuticals stock price today?▼
The current price of ADMS is $8.22 USD — it has increased by +0.74% in the past 24 hours. Watch Adamas Pharmaceuticals stock price performance more closely on the chart.
What is Adamas Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Adamas Pharmaceuticals stocks are traded under the ticker ADMS.
What is Adamas Pharmaceuticals market cap?▼
Today Adamas Pharmaceuticals has the market capitalization of 374.8M
How many employees does Adamas Pharmaceuticals have?▼
As of April 01, 2026, the company has 138 employees.
In which sector is Adamas Pharmaceuticals located?▼
Adamas Pharmaceuticals operates in the Manufacturing sector.
When did Adamas Pharmaceuticals complete a stock split?▼
Adamas Pharmaceuticals has not had any recent stock splits.
Where is Adamas Pharmaceuticals headquartered?▼
Adamas Pharmaceuticals is headquartered in Emeryville, US.